Andrew H. Limper
Consultant, Division of Pulmonary, Critical Care, Allergy, and Sleep Medicine, Department of Internal Medicine · Mayo Clinic
Credentials: · · ·
History
- Present
Research
Review · New England Journal of Medicine · 2004 · 778 citations
Proceedings of the National Academy of Sciences of the United States of America · 1991 · 735 citations
Mayo Clinic Proceedings · 1996 · 493 citations
42 papers
23 papers · 8 as a fellow
21 papers · 8 as a fellow
- TD
17 papers · 7 as a fellow
14 papers
11 papers
11 papers
10 papers
Grants
- 2026–2028
National Institute of Allergy and Infectious Diseases · R21
Contact PI · $242.1K · Mayo Clinic Rochester
- 2026–2028
“Targeting Phosphoglucomutase in Pneumocystis Pneumonia”
National Institute of Allergy and Infectious Diseases · R21
Contact PI · $441.1K · Mayo Clinic Rochester
- 1993–2027
Pneumocystis: Macrophage & Epithelial Activation
National Heart, Lung, and Blood Institute · R01
Contact PI · $9.7M · Mayo Clinic Rochester
- 2023–2025
The Role of the EphA2 Receptor Kinase Pathway in Pneumocystis Pneumonia (PCP)
National Institute of Allergy and Infectious Diseases · R21
Contact PI · $437.8K · Mayo Clinic Rochester
Clinical trials
- 2025–2031
An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
Site PI · Recruiting · Phase 2
Avalyn Pharma Inc.